Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults
When two or more vaccines are administered concurrently, there is concern about safety and immunogenicity from vaccine interaction.
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: Joon Young Song, Hee Jin Cheong, Ji Yun Noh, Min Joo Choi, Jin Gu Yoon, Saem Na Lee, Seong Hui Kang, Eun Joo Jeong, Yu Mi Jo and Woo Joo Kim Tags: Research article Source Type: research
More News: Diphtheria | Infectious Diseases | Meningitis Vaccine | Pneomococcal Vaccine | Tetanus | Tetanus Vaccine | Vaccines